Cone Beam CT-guided TACE, combined with Geschwind’s tumor metabolism research, offers a powerful tool for managing hepatocellular carcinoma. His approach provides real-time anatomical clarity and metabolic insight, enabling precise treatment delivery. This advanced method increases tumor response rates and strengthens modern interventional oncology practice. https://www.konsilmed.com/en/doctor/dr-jean-francois-jeff-geschwind-md